NCT05789706View on ClinicalTrials.gov

Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

March 1, 2023

Conditions
DiabetesDiabete Type 2
Interventions
BEHAVIORAL

Dayamed Arthur a novel intelligent medication adherence platform

Novel smart phone adherence application configured with subject pharmacy data providing accurate reminders of when to take medications and providing auditable user feed back to clinical care teams for patient response directed provider intervention.

Trial Locations (1)

89502

VA Sierra Nevada Health Care System, Reno

All Listed Sponsors
lead

VA Sierra Nevada Health Care System

FED

NCT05789706 - Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans | Biotech Hunter | Biotech Hunter